A Pilot, Randomized Sham Control Trial of Autologous Bone Marrow Derived Mononuclear Cells in Acute Ischemic Central Retinal Vein Occlusion
Journal Title: Journal of Advances in Medicine and Medical Research - Year 2016, Vol 13, Issue 2
Abstract
In this pilot, sham controlled randomized control trial (RCT) in patients with ischemic central retinal vein occlusion (CRVO), we studied the safety and efficacy of intravitreal injection of autologous bone marrow derived mononuclear cells and found that both patients who received stem cell injections did not develop anterior segment neovascularization at 1 year follow up. Except for some sterile inflammatory reaction in the initial follow up, no long term injection related serious adverse events (SAEs) were observed. Based on our observations we recommend a larger, multicentric study to further establish the safety and efficacy of this treatment in patients with ischemic CRVO. Purpose: To study the safety and efficacy of autologous bone marrow derived mononuclear cells injected intravitreally in patients with ischemic CRVO. Study Design: Randomized sham controlled trial. Methods: 4 cases with ischemic CRVO were recruited into the study. 2 cases were randomized into intervention group and 2 into control group. Baseline investigations included best corrected visual acuity (BCVA), intra ocular pressure (IOP), fundus fluorescein angiography (FFA), gonioscopy and optical coherence tomography (OCT). Patients in the intervention group received intravitreal injection of autologous bone marrow derived mononuclear cells (MNCs) and those in control group received sham injection. Patients were followed up over a 12-month period. Main Outcome Measures: Development of anterior segment neovascularization. Results: Both patients in the intervention group did not develop anterior segment neovascularization over a follow up period of 12 months. 1 patient in control group developed neovascularization of iris and elevated intra ocular pressure over a follow up period of 6 weeks and required trabeculectomy for control of IOP. The other patient in control group was lost follow up after 2 weeks. Conclusions: Our initial observations suggest that intravitreal injection of mononuclear cells may reduce the risk of developing anterior segment neovascularization in patients with ischemic central retinal vein occlusion. A larger, multicentric study would be valuable to gain further evidence to our preliminary observations.
Authors and Affiliations
Pradeep Venkatesh, Atul Kumar, Sujata Mohanty, Tullika Seth, Varun Gogia, Ramanjit Sihota, Yog Raj Sharma
Keywords
Related Articles
- EP ID EP340172
- DOI 10.9734/BJMMR/2016/20784
- Views 49
- Downloads 0
Parameters to Guide Rescue Therapy for Intravenous Immunoglobulin-resistant Kawasaki Disease
Aims: To identify the most useful parameter to guide rescue therapy among the IVIG-resistant patients who received an initial single IVIG therapy dose with a delayed use of anti-inflammatory drugs (DUA) for Kawasaki dise...
An Incomplete Ectrodactyly Ectodermal Cleft Syndrome – A Case Report
Ectrodactyly ectodermal dysplasia and clefting syndrome (EEC syndrome) is a rare genetic anomaly involving multiple structures and organ systems. It can be due to spontaneous mutation or autosomal dominant inheritance. T...
Psychiatric Morbidity among Subjects with Vesicovaginal Fistula in Abakaliki, South East Nigeria
Background: Vesicovaginal fistula (VVF) imposes enormous challenges on those affected. Subjects may have difficulties in coping and as a result may manifest specific mental disorders. Objective: This study determined the...
Knowledge of Stroke Risk Factors among Individuals Diagnosed with Hypertension and Diabetes: A Hospital-based Survey
Background: Stroke is a major cause of mortality and morbidity worldwide and primary prevention, through adequate knowledge of its risk factors and attendant risk factor control/modification, remains the best solution. T...
Erythropoietin Improves Effects of Mesenchymal Stem Cells in Experimental Endotoxemia
Aims: Sepsis is a leading cause of mortality in intensive care units. Development of new strategies such as the therapy with mesenchymal stem cells (MSC) appears beneficial for the treatment of sepsis. In this study we e...